Dong Tien Dinh

Dr. Dong Tien Dinh

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Gastroenterology Insights
Verified
Journal Article
Open access
PDF file
DHDuong Quang Huy
Duong Quang Huy
NCNguyen Van Chung
Nguyen Van Chung
DDDong Tien Dinh
Dong Tien Dinh
Background: Upper gastrointestinal (GI) hemorrhage, caused by acute esophageal variceal bleeding, is a common complication and a leading cause of death in patients with cirrhosis. Therefore, predicting the risk in order to employ an active management to prevent rebleeding and death is crucial. Currently, there are many prognostic scoring systems that have been proposed, but research is needed to find a valid score which can be applied in clinical practice in each country and population. Aims: To compare the value of ALBI (Albumin-Bilirubin), PALBI (Platelet Albumin-Bilirubin), AIMS65, model for end-stage liver disease (MELD), and Child–Pugh scores (CPS) approaches in predicting early rebleeding and in-hospital mortality of acute variceal bleeding in patients with cirrhosis. Subjects and methods: We performed a cross-sectional descriptive study on cirrhotic patients with acute variceal bleeding who were being treated at the Department of Gastroenterology, Intensive care unit—Military Hospital 103 and the Institute for Treatment of Digestive Diseases—108 Military Central Hospital from September 2020 to May 2022. We calculated ALBI, PALBI, AIMS65, MELD, Child–Pugh values and compared them with the rates of early rebleeding and in-hospital mortality. Then, determined and compared the prognostic value through an analysis of the area under the curve (AUC). Results: 222 patients with acute esophageal variceal bleeding were eligible for inclusion in the study. The rates of rebleeding and in-hospital mortality were 9.0% and 6.8%, respectively. Regarding the prognosis of early rebleeding, the ALBI and PALBI scores have good prognostic value (AUROC 0.74; 95% CI: 0.63–0.85 and AUROC 0.7; 95% CI: 0.59–0.81; p = 0.004, respectively), while the Child–Pugh, MELD, AIMS65 scores have little prognostic value, with AUROC < 0.70. Regarding prognosis of in-hospital mortality: the ALBI, PALBI, MELD and AIMS65 all have good value in predicting in-hospital mortality, with AUROC of 0.81 (95% CI: 0.68–0.93, respectively; p < 0.001); 0.8 (95% CI: 0.69–0.91; p <0.001); 0.83 (95% CI: 0.72–0.93; p < 0.001); and 0.82 (95% CI: 0.76–0.87, p < 0.001), respectively. While Child–Pugh score only has medium prognostic value, with AUROC 0.79 (95% CI: 0.66–0.92; p < 0.05). However, there was no significant difference between these prognostic scoring systems. Conclusion: the ALBI, PALBI, MELD and AIMS65 scores all had similar good value in predicting in-hospital mortality, but with early rebleeding prognosis, only ALBI and PALBI had good value. CPS does not show prognostic value like other scores, both in predicting early rebleeding and in-hospital mortality.

10 June 2022 in Toxics
Verified
Journal Article
Open access
PDF file
PPPhu Quang Pham
Phu Quang Pham
BNBa Vuong Nguen
Ba Vuong Nguen
TTTai Pham The
Tai Pham The
NDNhuong Xuan Duong
Nhuong Xuan Duong
HNHa Trong Nguyen
Ha Trong Nguyen
PTPham Ngoc Thao
Pham Ngoc Thao
We investigated changes in some laboratory indices and the liver histology of chronic hepatitis patients who were exposed to dioxin. In 2014, we collected liver biopsy samples for histopathological examination from 33 chronic hepatitis patients living around the Da Nang Airbase, which is a dioxin-contaminated area due to the herbicide spraying in Vietnam. Dioxin exposure was measured by its levels in the blood. METAVIR classification was used to clarify the liver fibrosis stage. Laboratory tests included ten biochemical and six hematological indices that were measured in the blood. A regression linear model and binary logistic regression were used for data analysis. The observed alterations in the liver at the histological level mainly comprised hydropic degenerative hepatocytes, lymphocytes and polynuclear leukocytes surrounding the liver cells and granular and lipoic degeneration. In addition, increased TCDD levels were associated with increasing aminotransferase (AST), alanine aminotransferase, protein and total bilirubin levels and liver fibrosis stage. Similarly, increased TEQ-PCDD/Fs levels were associated with higher levels of AST and protein and liver fibrosis stage. In conclusion, dioxin exposure altered the liver histology and increased some biochemical marker indices and the liver fibrosis stage of chronic hepatitis patients living in dioxin-contaminated areas in Da Nang, Vietnam.

28 August 2026 in VietNam Military Medical Unisversity
Verified
Journal Article
Open access
PDF file
TLThị Hương Quỳnh Lê
Thị Hương Quỳnh Lê
QDQuang Huy Dương
Quang Huy Dương
DDDong Tien Dinh
Dong Tien Dinh
Mục tiêu: Đánh giá sự thay đổi chức năng gan và phân tích một số yếu tố liên quan ở bệnh nhân (BN) ung thư biểu mô tế bào gan (UTBMTBG) sau điều trị hóa tắc mạch (transarterial chemoembolization - TACE). Phương pháp nghiên cứu: Nghiên cứu mô tả cắt ngang kết hợp theo dõi dọc trên 81 BN UTBMTBG được điều trị TACE tại Bệnh viện Quân y 103 từ tháng 4/2024 - 4/2026. Các chỉ số chức năng gan (AST, ALT, bilirubin, albumin, INR), phân độ Child-Pugh và ALBI (albumin-bilirubin) được đánh giá trước và sau điều trị 1 tháng. Phân tích mối liên quan giữa sự thay đổi chức năng gan với các yếu tố lâm sàng và cận lâm sàng. Kết quả: Sau 1 tháng điều trị TACE, các chỉ số enzyme gan, bilirubin tăng, trong khi albumin giảm có ý nghĩa so với trước điều trị (p < 0,05). BN có suy giảm chức năng gan (điểm Child-Pugh tăng ≥ 1) chiếm tỷ lệ đáng kể. Sự thay đổi chức năng gan liên quan đến gánh nặng khối u, giai đoạn bệnh và một số chỉ số sinh hóa trước điều trị. Kết luận: TACE ảnh hưởng đáng kể đến chức năng gan trong giai đoạn sớm sau điều trị. Việc đánh giá chức năng gan sau điều trị TACE có ý nghĩa quan trọng trong tiên lượng và lựa chọn định hướng điều trị tiếp theo.